Advantages and application of label-free detection assays in drug screening

Brian T. Cunningham, Lance G. Laing

Research output: Contribution to journalReview article

Abstract

Background: Adoption is accelerating for a new family of label-free optical biosensors incorporated into standard format microplates owing to their ability to enable highly sensitive detection of small molecules, proteins and cells for high-throughput drug discovery applications. Objective: Label-free approaches are displacing other detection technologies owing to their ability to provide simple assay procedures for hit finding/validation, accessing difficult target classes, screening the interaction of cells with drugs and analyzing the affinity of small molecule inhibitors to target proteins. Methods: This review describes several new drug discovery applications that are under development for microplate-based photonic crystal optical biosensors and the key issues that will drive adoption of the technology. Results/conclusions: Microplate-based optical biosensors are enabling a variety of cell-based assays, inhibition assays, protein-protein binding assays and protein-small molecule binding assays to be performed with high-throughput and high sensitivity.

Original languageEnglish (US)
Pages (from-to)891-901
Number of pages11
JournalExpert Opinion on Drug Discovery
Volume3
Issue number8
DOIs
StatePublished - Aug 1 2008

Fingerprint

Preclinical Drug Evaluations
Biosensing Techniques
Drug Discovery
Optics and Photonics
Technology
Proteins
Protein Binding
Cell Communication
Carrier Proteins
Pharmaceutical Preparations

Keywords

  • Cell-based assays
  • Label-free
  • Optical biosensors
  • Photonic crystal
  • Small molecule screening

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Advantages and application of label-free detection assays in drug screening. / Cunningham, Brian T.; Laing, Lance G.

In: Expert Opinion on Drug Discovery, Vol. 3, No. 8, 01.08.2008, p. 891-901.

Research output: Contribution to journalReview article

@article{9bee117bb61c44aab859cf85e995bc86,
title = "Advantages and application of label-free detection assays in drug screening",
abstract = "Background: Adoption is accelerating for a new family of label-free optical biosensors incorporated into standard format microplates owing to their ability to enable highly sensitive detection of small molecules, proteins and cells for high-throughput drug discovery applications. Objective: Label-free approaches are displacing other detection technologies owing to their ability to provide simple assay procedures for hit finding/validation, accessing difficult target classes, screening the interaction of cells with drugs and analyzing the affinity of small molecule inhibitors to target proteins. Methods: This review describes several new drug discovery applications that are under development for microplate-based photonic crystal optical biosensors and the key issues that will drive adoption of the technology. Results/conclusions: Microplate-based optical biosensors are enabling a variety of cell-based assays, inhibition assays, protein-protein binding assays and protein-small molecule binding assays to be performed with high-throughput and high sensitivity.",
keywords = "Cell-based assays, Label-free, Optical biosensors, Photonic crystal, Small molecule screening",
author = "Cunningham, {Brian T.} and Laing, {Lance G.}",
year = "2008",
month = "8",
day = "1",
doi = "10.1517/17460441.3.8.891",
language = "English (US)",
volume = "3",
pages = "891--901",
journal = "Expert Opinion on Drug Discovery",
issn = "1746-0441",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Advantages and application of label-free detection assays in drug screening

AU - Cunningham, Brian T.

AU - Laing, Lance G.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Background: Adoption is accelerating for a new family of label-free optical biosensors incorporated into standard format microplates owing to their ability to enable highly sensitive detection of small molecules, proteins and cells for high-throughput drug discovery applications. Objective: Label-free approaches are displacing other detection technologies owing to their ability to provide simple assay procedures for hit finding/validation, accessing difficult target classes, screening the interaction of cells with drugs and analyzing the affinity of small molecule inhibitors to target proteins. Methods: This review describes several new drug discovery applications that are under development for microplate-based photonic crystal optical biosensors and the key issues that will drive adoption of the technology. Results/conclusions: Microplate-based optical biosensors are enabling a variety of cell-based assays, inhibition assays, protein-protein binding assays and protein-small molecule binding assays to be performed with high-throughput and high sensitivity.

AB - Background: Adoption is accelerating for a new family of label-free optical biosensors incorporated into standard format microplates owing to their ability to enable highly sensitive detection of small molecules, proteins and cells for high-throughput drug discovery applications. Objective: Label-free approaches are displacing other detection technologies owing to their ability to provide simple assay procedures for hit finding/validation, accessing difficult target classes, screening the interaction of cells with drugs and analyzing the affinity of small molecule inhibitors to target proteins. Methods: This review describes several new drug discovery applications that are under development for microplate-based photonic crystal optical biosensors and the key issues that will drive adoption of the technology. Results/conclusions: Microplate-based optical biosensors are enabling a variety of cell-based assays, inhibition assays, protein-protein binding assays and protein-small molecule binding assays to be performed with high-throughput and high sensitivity.

KW - Cell-based assays

KW - Label-free

KW - Optical biosensors

KW - Photonic crystal

KW - Small molecule screening

UR - http://www.scopus.com/inward/record.url?scp=48749127096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749127096&partnerID=8YFLogxK

U2 - 10.1517/17460441.3.8.891

DO - 10.1517/17460441.3.8.891

M3 - Review article

C2 - 23484966

AN - SCOPUS:48749127096

VL - 3

SP - 891

EP - 901

JO - Expert Opinion on Drug Discovery

JF - Expert Opinion on Drug Discovery

SN - 1746-0441

IS - 8

ER -